No registrations found.
ID
Source
Health condition
Calcification propensity.
Dialysis.
Vascular Calcification.
Sponsors and support
PO Box 5800
6202 AZ Maastricht, The Netherlands
Intervention
Outcome measures
Primary outcome
Calcification propensity of the serum measured by the transformation time from primary to secondary calciprotein particles (T50).
Secondary outcome
Increased vascular velocity measured by a pulse wave velocity meter.
Study objective
The use of lower concentrations of calcium dialysate and the use of calcium citrate dialysate improves calcicifaction propensity of serum of hemodialysis patients.
Study design
Change in dialysate composition will be during 1 week on dialysis.
Intervention
Change in dialysate calcium concentration and using calcium-citrate dialysate.
Marijke Dekker
Michelangelolaan 2
Eindhoven 5623 EJ
The Netherlands
marijke.dekker@mumc.nl
Marijke Dekker
Michelangelolaan 2
Eindhoven 5623 EJ
The Netherlands
marijke.dekker@mumc.nl
Inclusion criteria
Prevalent HD patients with a dialysis vintage of at least 3 months.
Hemodynamically stable on dialysis.
AV-fistula enabling double-needle vascular access with a blood flow rate of at least 300 ml/min.
Age above 18 years of age.
Informed consent.
Exclusion criteria
Withdrawal of consent
Acute intercurrent illness (infection, malignancy, cardiovascular event, uncontrolled diabetes)
Long QT syndrome
Frequent intra-dialytic hypotension (>10% of treatments)
Design
Recruitment
Followed up by the following (possibly more current) registration
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL5094 |
| NTR-old | NTR5226 |
| CCMO | NL53094.068.15 |
| OMON | NL-OMON44984 |